DalsnaFinance

Anavex Life Sciences Corp $AVXL

Health Care

Russell 2000 New York
Create a scorecard
$1.36
+0.00 (0.00%)
As of Oct 21, 2026, 6:58 PM EDT
Price history
Loading chart…

Anavex Life Sciences Corp (AVXL) is trading up at $1.36 (0.00%), as of the latest quote. It is a Russell 2000 constituent in the Health Care sector.

Anavex Life Sciences Corp net income history (FY2016–FY2025)

Net income
$0−$24.0M−$48.0MFY2016 net income: −$14.7M'16FY2017 net income: −$13.5M'17FY2018 net income: −$17.3M'18FY2019 net income: −$26.3M'19FY2020 net income: −$26.3M'20FY2021 net income: −$37.9M'21FY2022 net income: −$48.0M'22FY2023 net income: −$47.5M'23FY2024 net income: −$43.0M'24FY2025 net income: −$46.4M'25
Anavex Life Sciences Corp annual financial statements
FY2016Sep 2016FY2017Sep 2017FY2018Sep 2018FY2019Sep 2019FY2020Sep 2020FY2021Sep 2021FY2022Sep 2022FY2023Sep 2023FY2024Sep 2024FY2025Sep 2025
Income statement
Operating income————−$31.1M−$42.0M−$51.0M−$55.8M−$52.9M−$51.4M
Net income−$14.7M−$13.5M−$17.3M−$26.3M−$26.3M−$37.9M−$48.0M−$47.5M−$43.0M−$46.4M
EPS (diluted)−$0.42−$0.33−$0.39−$0.54−$0.45−$0.54−$0.62−$0.60−$0.52−$0.54
Balance sheet
Cash and equivalents$9.19M$27.4M$22.9M$22.2M$29.2M$152.1M$149.2M$151.0M$132.2M$102.6M
Total assets$9.50M$27.8M$26.2M$25.3M$34.5M$161.6M$152.7M$154.4M$135.6M$103.8M
Total liabilities$3.19M$3.58M$3.88M$5.04M$7.31M$10.8M$10.2M$12.5M$15.3M$8.95M
Shareholders' equity$6.31M$25.9M$22.3M$20.3M$27.2M$150.8M$142.5M$141.9M$120.3M$94.9M
Cash flow
Operating cash flow−$9.24M−$9.02M−$12.6M−$18.5M−$21.3M−$30.4M−$24.2M−$27.8M−$30.8M−$39.0M

From Anavex Life Sciences Corp's 10-K and 10-Q filings with the SEC; its fiscal year ends in September. Each period shows the latest figure the company has reported for it, including restatements. † Quarter derived from the company's year-to-date or full-year totals. Filings on SEC EDGAR →

About Anavex Life Sciences Corp

Headquarters
New York, New York From SEC filings, Oct 2026

Recent News (11)

More Health Care stocks

Browse all companies →